Actavis Announces Proposed Senior Management TeamBy
Actavis plc has announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of
Following the close of the deal,
In the newly created role of executive chairman, Bisaro will continue to lead the company’s board of directors while maintaining his oversight of the strategic management of Actavis. He, working with Saunders and the Actavis management team, will oversee the development of the company’s brand, generic, branded generic, and over-the-counter business growth strategies, as well as the identification and execution of mergers and acquisitions, including geographic and business unit diversification strategies and initiatives. He will also continue to share in directing senior management team selection and retention; overall business integration initiatives; strategic planning for both organic and inorganic growth; and in conjunction with Saunders, continue to represent the company with shareholders, investors, and other critical audiences.
As CEO and president, Mr. Saunders will have responsibility for leading
In the newly created position of chief operating officer, Stewart will retain responsibility for global operations, quality, supply chain, procurement, engineering and security, and information technology. In addition, he will retain responsibility for
To support the combined company’s more complex generic, brand, branded generic and OTC global commercial operations,
“Bill and David will form a dynamic team in guiding our innovative new commercial organization,” said Mr. Bisaro. “Bill’s extensive background across the Forest organization, including oversight of the company’s Global Commercial and U.S. Marketing, Sales, Managed Care,
To support the larger and more complex company,
The company noted that it anticipates continuing to define the subsequent levels within the global organization between now and the close of the acquisition.